-
1
-
-
33845944307
-
Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men
-
Cerfolio RJ, Bryant AS, Scott E, Sharma M, Robert F, Spencer SA, Garver RI 2006 Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men. Chest 130:1796-1802.
-
(2006)
Chest
, vol.130
, pp. 1796-1802
-
-
Cerfolio, R.J.1
Bryant, A.S.2
Scott, E.3
Sharma, M.4
Robert, F.5
Spencer, S.A.6
Garver, R.I.7
-
2
-
-
66649101572
-
Gender is an age-specific effect modifier for papillary cancers of the thyroid gland
-
Kilfoy BA, Devesa SS, Ward MH, Zhang Y, Rosenberg PS, Holford TR, Anderson WF 2009 Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev 18:1092-1100.
-
(2009)
Cancer Epidemiol Biomarkers Prev
, vol.18
, pp. 1092-1100
-
-
Kilfoy, B.A.1
Devesa, S.S.2
Ward, M.H.3
Zhang, Y.4
Rosenberg, P.S.5
Holford, T.R.6
Anderson, W.F.7
-
3
-
-
34447327216
-
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
-
Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M 2007 Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317:121-124.
-
(2007)
Science
, vol.317
, pp. 121-124
-
-
Naugler, W.E.1
Sakurai, T.2
Kim, S.3
Maeda, S.4
Kim, K.5
Elsharkawy, A.M.6
Karin, M.7
-
4
-
-
77952990855
-
Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription
-
Wu MH, Ma WL, Hsu CL, Chen YL, Ou JH, Ryan CK, Hung YC, Yeh S, Chang C 2010 Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Sci Transl Med 2:32ra35.
-
(2010)
Sci Transl Med
, vol.2
-
-
Wu, M.H.1
Ma, W.L.2
Hsu, C.L.3
Chen, Y.L.4
Ou, J.H.5
Ryan, C.K.6
Hung, Y.C.7
Yeh, S.8
Chang, C.9
-
5
-
-
66649089479
-
Sex disparities in cancer incidence by period and age
-
Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, Devesa SS, McGlynn KA 2009 Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev 18:1174-1182.
-
(2009)
Cancer Epidemiol Biomarkers Prev
, vol.18
, pp. 1174-1182
-
-
Cook, M.B.1
Dawsey, S.M.2
Freedman, N.D.3
Inskip, P.D.4
Wichner, S.M.5
Quraishi, S.M.6
Devesa, S.S.7
McGlynn, K.A.8
-
7
-
-
51549117737
-
-
accessed October 10, 2011
-
Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Horner MJ, Howlader N, Eisner MP, Reichman M, Edwards BK (eds) 2007 SEER cancer statistics review, 1975-2004. Available at: http://seer.cancer.gov/csr/1975- 2004 (accessed October 10, 2011).
-
(2007)
SEER Cancer Statistics Review, 1975-2004
-
-
Ries, L.A.G.1
Melbert, D.2
Krapcho, M.3
Mariotto, A.4
Miller, B.A.5
Feuer, E.J.6
Clegg, L.7
Horner, M.J.8
Howlader, N.9
Eisner, M.P.10
Reichman, M.11
Edwards, B.K.12
-
8
-
-
0031028402
-
Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the surveillance, epidemiology and end results (SEER) program 1973-1991
-
Gilliland FD, Hunt WC, Morris DM, Key CR 1997 Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 79:564-573.
-
(1997)
Cancer
, vol.79
, pp. 564-573
-
-
Gilliland, F.D.1
Hunt, W.C.2
Morris, D.M.3
Key, C.R.4
-
10
-
-
0013401756
-
-
National Cancer Institute, U.S. National Institutes of Health. (accessed May 21, 2012)
-
National Cancer Institute, U.S. National Institutes of Health 2012 Surveillance Epidemiology and End Results: ICD-O-3 Coding Materials. Available at: http://seer.cancer.gov/ icd-o-3 (accessed May 21, 2012).
-
(2012)
Surveillance Epidemiology and End Results: ICD-O-3 Coding Materials
-
-
-
12
-
-
0343384367
-
Papillary thyroid carcinoma: Prognostic index for survival including the histological variety
-
Sebastian SO, Gonzalez JM, Paricio PP, Perez JS, Flores DP, Madrona AP, Romero PR, Tebar FJ 2000 Papillary thyroid carcinoma: prognostic index for survival including the histological variety. Arch Surg 135:272-277.
-
(2000)
Arch Surg
, vol.135
, pp. 272-277
-
-
Sebastian, S.O.1
Gonzalez, J.M.2
Paricio, P.P.3
Perez, J.S.4
Flores, D.P.5
Madrona, A.P.6
Romero, P.R.7
Tebar, F.J.8
-
13
-
-
41549162818
-
Papillary thyroid carcinoma: Factors influencing recurrence and survival
-
Toniato A, Boschin I, Casara D, Mazzarotto R, Rubello D, Pelizzo M 2008 Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol 15:1518-1522.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 1518-1522
-
-
Toniato, A.1
Boschin, I.2
Casara, D.3
Mazzarotto, R.4
Rubello, D.5
Pelizzo, M.6
-
14
-
-
84863988009
-
Prognostic factors in differentiated thyroid cancer-A 20-year surgical outcome study
-
Konturek A, Barczynski M, Nowak W, Richter P 2012 Prognostic factors in differentiated thyroid cancer-A 20-year surgical outcome study. Langenbecks Arch Surg 397:809-815.
-
(2012)
Langenbecks Arch Surg
, vol.397
, pp. 809-815
-
-
Konturek, A.1
Barczynski, M.2
Nowak, W.3
Richter, P.4
-
15
-
-
80053272812
-
Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases
-
Yu XM, Wan Y, Sippel RS, Chen H 2011 Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg 254:653-660.
-
(2011)
Ann Surg
, vol.254
, pp. 653-660
-
-
Yu, X.M.1
Wan, Y.2
Sippel, R.S.3
Chen, H.4
-
16
-
-
84857059352
-
The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis
-
Yoon YH, Kim HJ, Lee JW, Kim JM, Koo BS 2012 The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinolaryngol 269:1013-1017.
-
(2012)
Eur Arch Otorhinolaryngol
, vol.269
, pp. 1013-1017
-
-
Yoon, Y.H.1
Kim, H.J.2
Lee, J.W.3
Kim, J.M.4
Koo, B.S.5
|